Vol 17, No 3S (2016)

Table of Contents

Supplement

[Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market]
Lorenzo Pradelli, Paolo Ascierto
HTML PDF
1-32